Single application hybrid interstitial brachytherapy for cervical cancer: An institutional approach during the COVID-19 pandemic

Authors:

Abstract
Introduction To ease anesthesia and inpatient strain during the COVID-19 pandemic, our institution’s policy for hybrid intracavitary-interstitial brachytherapy (IC/ISBT) for cervical cancer (CC) was modified from multiple applications (MA) treated over 2 separate weeks (7 Gy × 4) to a...

This publication has 9 references indexed in Scilit: